US 12195804
Treatment of squamous cell carcinoma
granted A61KA61K31/53A61K31/5377
Quick answer
US patent 12195804 (Treatment of squamous cell carcinoma) held by The Board of Regents of the University of Texas System expires Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jan 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/53, A61K31/5377, A61K45/06